tiprankstipranks
Trending News
More News >
SpectraCure AB (SE:SPEC)
:SPEC

SpectraCure AB (SPEC) Price & Analysis

Compare
0 Followers

SPEC Stock Chart & Stats


---

Financials

SPEC FAQ

What was SpectraCure AB’s price range in the past 12 months?
SpectraCure AB lowest stock price was kr0.68 and its highest was kr5.11 in the past 12 months.
    What is SpectraCure AB’s market cap?
    SpectraCure AB’s market cap is kr75.57M.
      When is SpectraCure AB’s upcoming earnings report date?
      SpectraCure AB’s upcoming earnings report date is Aug 21, 2025 which is in 93 days.
        How were SpectraCure AB’s earnings last quarter?
        SpectraCure AB released its earnings results on Feb 20, 2025. The company reported -kr0.048 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.048.
          Is SpectraCure AB overvalued?
          According to Wall Street analysts SpectraCure AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does SpectraCure AB pay dividends?
            SpectraCure AB does not currently pay dividends.
            What is SpectraCure AB’s EPS estimate?
            SpectraCure AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does SpectraCure AB have?
            SpectraCure AB has 97,131,610 shares outstanding.
              What happened to SpectraCure AB’s price movement after its last earnings report?
              SpectraCure AB reported an EPS of -kr0.048 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -18.772%.
                Which hedge fund is a major shareholder of SpectraCure AB?
                Currently, no hedge funds are holding shares in SE:SPEC
                ---

                Company Description

                SpectraCure AB

                SpectraCure AB (SPEC) is a medical technology company focused on developing innovative cancer treatment solutions. The company specializes in photodynamic therapy (PDT), a minimally invasive treatment method that uses laser technology to activate a photosensitive drug for the effective targeting and destruction of cancer cells. SpectraCure primarily targets hard-to-treat cancers, such as prostate cancer, with its proprietary Interstitial Photodynamic Therapy (IPDT) system designed to improve patient outcomes and reduce side effects associated with traditional cancer treatments.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Acarix AB
                Clinical Laserthermia Systems AB Class B
                Q-linea AB
                SciBase Holding AB
                Scandinavian Real Heart AB
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis